吉林長龍藥業：環境、社會及管治報告2023.pdf

1、2023Environmental,Social and Governance Report環境、社會及管治報告Stock Code 股份代號:8049吉林省輝南長龍生化藥業股份有限公司二零二三年環境、社會及管治報告1ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT環境、社會及管治報告ABOUT THE REPORTJilin Province Huinan Changlong Bio-pharmacy Company Limited(the“Company”or“we”)and its subsidiaries(collectively referred

2、to as the“Group”)is committed to the long-term sustainability of its businesses and the communities with which it engages.The Group pursues the business approach of managing its businesses prudently and executing management decisions with due care and attention.In addition,the Group is committed to

3、improving its environmental,social and governance(“ESG”)performance by upholding good corporate governance standards,protecting the environment,engaging the community and promoting social integration.The Companys board of directors(the“Board”)takes the overall responsibility for the Groups ESG issue

4、s,and needs to define ESG management guidelines,strategies,priorities and objectives.Assisted by ESG consultants,members of the Board have had the proper skills,experience,knowledge and views needed to supervise the Groups ESG issues.To better manage the Groups performance,issues and potential risks

5、 relating to ESG,the Board,at least once a year,collectively discusses ESG issues,evaluates and identifies the Groups ESG risks and opportunities,reviews the importance of ESG issues,and analyzes its performance and progress based on ESG related targets.Also,the Board is responsible for the effectiv

6、eness of risk management and internal control systems,and approves the information disclosed in the ESG reports.The Groups management assists the Board in the supervision of ESG issues,collecting and analysing ESG data,monitoring and evaluating the Groups ESG performance,following up with and review